METILDA 50850 MG

Šalis: Izraelis

kalba: anglų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

METFORMIN HYDROCHLORIDE; VILDAGLIPTIN

Prieinama:

TEVA ISRAEL LTD

ATC kodas:

A10BA02

Vaisto forma:

FILM COATED TABLETS

Sudėtis:

METFORMIN HYDROCHLORIDE 850 MG; VILDAGLIPTIN 50 MG

Vartojimo būdas:

PER OS

Recepto tipas:

Required

Pagaminta:

TEVA ISRAEL LTD, ISRAEL

Gydymo sritis:

METFORMIN

Terapinės indikacijos:

Metilda 50/850 mg is indicated in the treatment of type 2 diabetes mellitus: - Vildagliptin/Metformin Teva is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets. - Vildagliptin/Metformin Teva is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea. - Vildagliptin/Metformin Teva is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

Leidimo data:

2023-05-23

Pakuotės lapelis

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s prescription only
Metilda
50/850 mg
Metilda
50/1000 mg
Film-coated tablets
Film-coated tablets
Composition:
Each tablet contains:
Metilda 50/850 mg:
Vildagliptin 50 mg and metformin hydrochloride 850 mg
Metilda 50/1000 mg:
Vildagliptin 50 mg and metformin hydrochloride 1,000 mg
Inactive ingredients: see section 6 “Additional information”.
Read the entire leaflet carefully before using the medicine. This
leaflet
contains concise information about the medicine. If you have
additional
questions, refer to the doctor or the pharmacist.
This medicine has been prescribed for treatment of your illness. Do
not pass
it on to others. It may harm them even if it seems to you that their
illness is
similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
Both active ingredients are oral antidiabetic medicines.
•
Metilda is intended for treatment of type 2 diabetes. Metilda is
intended for
treatment in adults already receiving combined treatment with separate
tablets of vildagliptin and metformin hydrochloride, or whose diabetes
is
not adequately controlled with metformin hydrochloride alone.
The doctor will prescribe treatment with Metilda either alone or in
combination
with another diabetes medicine, depending on your condition. Metilda
is also
intended for treatment in adults in combination with insulin or with a
medicine
from the sulfonylurea group, together with diet and exercise.
Therapeutic class:
Vildagliptin – dipeptidyl-peptidase-4 (DPP-4) inhibitor.
Metformin – biguanides.
Type 2 diabetes develops when the body does not produce enough
insulin,
when the insulin that the body produces does not work properly or when
the
body produces too much glucagon.
Insulin is a substance which helps to lower the level of glucose in
the blood,
especially after meals. Glucagon is a substance that stimulates the
liver
to produce glucose, causing the blood glucose level to rise. Both of
these
substances a